It has been postulated that different HCC therapies such as radiofrequency ablation or TACE lead to an activation and enhancement of TAA-specific CD8+ T-cell responses probably reflecting activation by antigen release and/or induction of danger signals by tumor necrosis and or apoptosis [6, 23, 29–31]. Here, CD8A is linked to hepatocellular carcinoma.